GK Wealth Management LLC Boosts Stock Holdings in UnitedHealth Group Incorporated $UNH

GK Wealth Management LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 7.2% in the first quarter, Holdings Channel reports. The institutional investor owned 506 shares of the healthcare conglomerate’s stock after acquiring an additional 34 shares during the quarter. GK Wealth Management LLC’s holdings in UnitedHealth Group were worth $265,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds also recently made changes to their positions in the company. Citizens National Bank Trust Department grew its holdings in UnitedHealth Group by 1.0% during the 1st quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate’s stock valued at $9,368,000 after buying an additional 170 shares in the last quarter. Fort Washington Investment Advisors Inc. OH grew its stake in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate’s stock valued at $277,641,000 after acquiring an additional 1,465 shares in the last quarter. Caitlin John LLC grew its stake in UnitedHealth Group by 14.8% during the first quarter. Caitlin John LLC now owns 862 shares of the healthcare conglomerate’s stock valued at $451,000 after acquiring an additional 111 shares in the last quarter. Sherbrooke Park Advisers LLC purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $515,000. Finally, Silvercrest Asset Management Group LLC grew its position in shares of UnitedHealth Group by 47.8% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 38,796 shares of the healthcare conglomerate’s stock valued at $19,625,000 after purchasing an additional 12,550 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Performance

NYSE UNH opened at $347.27 on Thursday. The firm has a market cap of $314.51 billion, a price-to-earnings ratio of 15.05, a PEG ratio of 2.27 and a beta of 0.45. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73. The company has a 50-day simple moving average of $290.20 and a two-hundred day simple moving average of $371.22. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). The company had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The company’s revenue was up 12.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

Wall Street Analyst Weigh In

Several equities analysts recently commented on UNH shares. Robert W. Baird restated an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Royal Bank Of Canada cut their price target on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. JPMorgan Chase & Co. cut their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research note on Wednesday, August 6th. Wells Fargo & Company cut their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Finally, TD Securities reiterated a “hold” rating and issued a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a report on Monday, May 19th. Sixteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. Based on data from MarketBeat, UnitedHealth Group has a consensus rating of “Moderate Buy” and a consensus price target of $355.77.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.